Are Banco Santander SA, Smurfit Kappa Group Public Ltd Co-Ord Sh & Animalcare Group Plc Brilliant Buys?

Royston Wild considers the investment appeal of Banco Santander SA (LON: BNC), Smurfit Kappa Group Public Ltd Co-Ord Sh (LON: SKG) and Animalcare Group Plc (LON: ANCR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am running the rule over three Wednesday headline makers.

Box up a beauty

Packaging specialists Smurfit Kappa (LSE: SKG) furnished the market with consensus-beating numbers in Wednesday’s session, news which sent the firm’s shares spiralling 15% higher from Tuesday’s close.

The Dublin-based business — which also advised today that it is seeking a premium listing on the London Stock Exchange — saw pre-tax profit leap 58%, to €599m, during 2015, even though revenues only moved marginally higher to €8.11bn.

And Smurfit Kappa believes it has built a robust base upon which to “deliver good earnings growth in 2016,” the firm having splashed out €380m in acquisitions last year alone and an additional €450m to improve its existing asset and project quality.

The City certainly believes Smurfit Kappa has plenty left in the tank, and a predicted 17% earnings increase this year leaves the stock dealing on an ultra-low P/E rating of 9.2 times. And when you factor in a projected dividend of 73 euro cents per share — yielding a handy 2.9% — I believe the Irish packagers are a great long-term selection for value seekers.

Animal magic

Veterinary care provider Animalcare (LSE: ANCR) has not fared as well on Wednesday after releasing choppy half-year numbers, and was last dealing 2% lower on the day.

Animalcare saw total revenues advanced 2.7% between July and December, to £7.11m, with strong growth at its Licensed Veterinary Medicines unit shrugging off the problem of tough comparatives. This solid top-line performance was not enough to stop pre-tax profit sinking 12.9% during the period to £1.53m, however.

Still, I believe investors in Animalcare still have plenty to be excited about. The York-based business has invested huge sums to improve its sales teams and marketing strategy to facilitate future revenues growth, while its bubbly product pipeline is anticipated to enhance earnings from 2017.

In the meantime Animalcare is expected to chalk up a 7% earnings dip in the year to June 2016, resulting in an slightly-elevated P/E rating of 20 times. But I believe the firm’s growing position in a rapidly-expanding market should deliver solid earnings expansion in the longer term.

Bank heading lower

Market appetite for the banking sector has imploded in recent weeks, as fears concerning firms’ exposure to worsening commodity markets — combined with concerns over the financial health of emerging markets — have intensified.

Global banking giant Santander (LSE: BNC) has seen its share price fall to fresh multi-year troughs in February, and the firm has shed 40% of its value since during the past 12 months alone. And further pain could well be on the cards as the Brazilian economy continues to flail and the real sinks in value — Santander sources a fifth of total profits from the country.

And Santander’s precarious growth outlook, combined with a flimsy balance sheet, is casting doubt on the firm’s ability to generate market-beating dividends.

The outlook is far from catastrophic at the present time, however, and the City expects Santander to enjoy a 5% earnings uptick in 2016, resulting in an ultra-low P/E rating of 6.8 times. And predictions of another 20-euro-cent-per-share dividend creates a very-decent yield of 5.7%.

But I believe downgrades to these forecasts could be on the horizon as conditions in the bank’s key marketplaces keep deteriorating.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

1 Warren Buffett stock I’m buying now

Coca-Cola is the fourth-largest holding in Warren Buffett’s Berkshire Hathaway. I’ll explain why I’m following Buffett and buying more.

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

I bought 4,403 Lloyds shares in June and 4,856 in September. Here’s what they’re worth now

Harvey Jones thought he was bagging a FTSE 100 bargain when he bought Lloyds shares on two occasions last year.…

Read more »

Young woman holding up three fingers
Investing Articles

I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA

Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only…

Read more »

Close up of a group of friends enjoying a movie in the cinema
Investing Articles

How I’d try and turn just £1 a day into a fabulous £54,485 passive income for life

By investing small, regular sums in FTSE 100 shares I can potentially generate a huge passive income stream. It won't…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’d aim for a million buying under a dozen shares

Christopher Ruane explains why less could be more when it comes to building a share portfolio if he wants to…

Read more »

Investing Articles

Rolls-Royce shares are up over 1,000% since 2020! Am I too late to buy?

Rolls-Royce shares now cost over tenfold what they did in the firm's 2020 rights issue. Our writer thinks they may…

Read more »

Investing Articles

1 top UK growth stock for my tech portfolio in 2024

Up 30% in just one year, this growth stock looks positioned to continue on the path of substantial gains, according…

Read more »

Buffett at the BRK AGM
Investing Articles

I’d follow Warren Buffett to target effortless passive income

Warren Buffett knows a thing or two about building passive income streams. By learning from the Sage of Omaha, so…

Read more »